xml version="1.0" ? hrl-20220125

0000048465false00000484652022-01-252022-01-25

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 8-K 

CURRENT REPORT

Pursuant to Section 13 or 15 (d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) January 25, 2022 

HORMEL FOODS CORPORATION 

(Exact name of registrant as specified in its charter)[DATA_TABLE_REMOVED]

1 Hormel Place 

Austin, MN 55912 

(Address of Principal Executive Office)

(507) 437-5611 

Registrant’s telephone number, including area code: 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[☐] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[☐] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[☐] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[☐] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:[DATA_TABLE_REMOVED]

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  [☐]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [☐]

Section 5 — CORPORATE GOVERNANCE AND MANAGEMENT

Item 5.07 Submission of Matters to a Vote of Security Holders

The Company conducted its annual stockholders’ meeting on January 25, 2022. 

At the annual meeting, 493,557,074 shares were represented (91.0 percent of the 542,569,949 shares outstanding and entitled to vote). Four items were considered at the meeting and the results of the voting were as follows: 

1.Election of Directors: The nominees in the proxy statement were: Prama Bhatt, Gary C. Bhojwani, Terrell K. Crews, Stephen M. Lacy, Elsa A. Murano, Ph.D., Susan K. Nestegard, William A. Newlands, Christopher J. Policinski, Jose Luis Prado, Sally J. Smith, James P. Snee, and Steven A. White. The results were as follows:[DATA_TABLE_REMOVED]

2. Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 30, 2022:

 [DATA_TABLE_REMOVED]

3. Advisory vote on the compensation of the Company’s Named Executive Officers, as disclosed in the Company’s 2022 annual meeting proxy statement (as filed with the Securities and Exchange Commission on December 15, 2021):

 [DATA_TABLE_REMOVED]

2

4. Stockholder proposal requesting a report on external public health costs of antimicrobial resistance:

 [DATA_TABLE_REMOVED]

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 [DATA_TABLE_REMOVED]

4